Press release
Global Mitotane Market 2023: Rising Demand for Adjuvant Therapy Offers Impetus | HRA Pharma, Bristol-Myers Squibb Company
Over the years, mitotane has become one the preferred choices of treatment for Cushing's syndrome and ACC. The growth of the mitotane market can be attributed to the increased incidence of patient population, which is anticipated to grow significantly in the forecast period. Furthermore, late recurrence of Cushing's syndrome and late diagnosis and detection also favours the growth of the mitotane market. ACC has been marked with a high recurrence rate, where treatment using adjuvant therapy has been found to be extremely successful.Request For Free Sample Report of "Mitotane Market"@ https://www.persistencemarketresearch.com/samples/30052
The ~US$ 12 billion market for mitotane is anticipated to grow at a healthy CAGR over the period of next decade. Macro-economic factors, such increase expenditure in healthcare sector in emerging nations such as China, India, and Brazil is expected to boost the growth of the mitotane market in the forecast period. With the rise and continual growth in global healthcare expenditure, sales of pharma drugs such as mitotane in countries outside the U.S. represent a potential growth avenue for domestic manufacturers.
According to the World Bank, all regions (except Sub-Saharan Africa) have seen an increase in the healthcare spending as a percentage of total output over the last two decades. Similarly, in 2016, China's healthcare expenditure grew ~5% of the GDP, which is expected to almost double by 2020.
The market for mitotane is based on two disease indications such as Cushing's syndrome and ACC. Cushing's syndrome includes symptoms such as round red face, high blood pressure, weak muscles and bones, abdominal obesity, a fat lump between shoulders, and fragile skin. The prevalence rate varies from 10-15 cases/ million population/year. High disease diagnosis screening percentage and attractive reimbursement in developed markets have made the mitotane market to grow significantly.
Companies
HRA Pharma
Bristol-Myers Squibb Company
Buy Full Report Now @ https://www.persistencemarketresearch.com/checkout/30052
In contrast, ACC is a rare but aggressive tumour that arises from adrenal cortex and develops late with a large mass. It is estimated that ~600 new cases are diagnosed every year/million population. The disease is most common between 50 and 60 years of age. According to PMR, ACC-based disease indication is anticipated to hold a prominent position in the global mitotane market, in terms of revenue with a global market share of ~60% in 2029.
Major players in the mitotane market are focusing on investing in research and development for the improvement of mitotane with less side effects, and introduction of more affordable and reliable drug treatments in developing regions of the world. Besides, companies are also engaged in commercial partnerships for the sales and marketing of mitotane. Such developments are likely to foster the market to grow in untapped regions and meet the treatment demand.
The mitotane market report offers a comprehensive taxonomy based on the disease indication, distribution channel, and region. Based on disease indication, the global mitotane market is segmented into ACC and Cushing's syndrome.
Based on distribution channel, the mitotane market is classified into hospital pharmacies, retail pharmacies, online pharmacies, and specialty clinics. With the increase in the incidence of both the diseases and growth opportunities in terms of sales, the mitotane market also offers significant potential for other players to invest in the market.
The mitotane market has been studied across North America, Latin America, Europe, East Asia, South Asia, Oceania, MEA, and Emerging countries such as China, Brazil, and India. Availability of knowledge-based resources and enhanced research collaboration trends in North America and Europe are estimated to propel the growth of the mitotane market. North America and Europe markets are projected to be the prominent regional markets for mitotane and are poised to offer substantial opportunities.
Request Customization @ https://www.persistencemarketresearch.com/request-customization/30052
Key Questions Answered in This Report.
What are the Roadblocks for Mitotane Market Suppliers?
What are the Key Opportunities for Mitotane Market Manufacturers?
How is Focus on Safety Influencing Mitotane Market Demand?
What is the Regulatory Impact on Global Sales of Mitotane Market?
Which Region Offers the Largest Opportunity for Sales of Mitotane Market?
Where Does the U.S. Stand in the Market for Mitotane Market?
What Is the Outlook for Mitotane Market Manufacturers in China?
Why is Germany a Lucrative Market for Mitotane Market Manufacturers?
Why Will Belgium Outpace Other European Markets for Mitotane Market?
Why is There High Demand for Tires in Mitotane Market?
Why are Sales of Mitotane Market Surging?
For More Premium Insights, Check out the Link:
Systemic Scleroderma Treatment Market - https://www.persistencemarketresearch.com/market-research/systemic-scleroderma-treatment-market.asp
Primary Hepatocytes Market - https://www.persistencemarketresearch.com/market-research/primary-hepatocytes-market.asp
Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com
About Us
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Mitotane Market 2023: Rising Demand for Adjuvant Therapy Offers Impetus | HRA Pharma, Bristol-Myers Squibb Company here
News-ID: 2878547 • Views: …
More Releases from Persistence Market Research

Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Pers …
➤ Overview of the Market
The global plastic liner market has gained steady traction across multiple industries due to its cost-effectiveness, versatility, and protective characteristics. Plastic liners are widely used in agriculture, mining, construction, waste management, and packaging industries, where they serve as an essential barrier to prevent leakage, contamination, and material loss. These liners are manufactured using materials such as polyethylene (PE), polypropylene (PP), and PVC, offering superior resistance to…

Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by S …
➤ Overview of the Market
The global returnable plastic crate market is gaining momentum as industries seek cost-effective and sustainable packaging solutions. These crates are widely used for transporting and storing perishable goods, beverages, pharmaceuticals, and industrial products due to their durability, stackability, and reusability. The shift from single-use packaging to eco-friendly alternatives has accelerated the adoption of returnable plastic crates across sectors. The market, valued at US$ 1,820.0 million in…

US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Gr …
➤Overview of the Market
The US thermal power market plays a crucial role in the nation's energy mix, serving as a stable and reliable source of electricity despite the rise of renewables. Thermal power plants in the US rely primarily on coal, natural gas, and oil to generate electricity, with natural gas emerging as the dominant fuel source due to its affordability, efficiency, and lower carbon footprint compared to coal. According…

Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Health …
➤Overview of the Market
The Europe medical plastic market is undergoing robust growth, fueled by increasing demand for lightweight, durable, and cost-effective materials in the healthcare sector. Medical plastics are widely used in devices, surgical instruments, diagnostic tools, implants, and packaging due to their high biocompatibility, versatility, and resistance to sterilization methods. With healthcare systems across Europe investing heavily in modernization and patient safety, the adoption of medical-grade plastics has gained…
More Releases for Mitotane
Global Mitotane Market 2022: Rising Demand for Adjuvant Therapy Offers Impetus
The Mitotane market is a significant sector within the pharmaceutical industry, as Mitotane (also known as o,p'-DDD or Lysodren) is a drug used to treat adrenocortical carcinoma, a rare type of cancer that affects the outer layer of the adrenal gland. Mitotane works by inhibiting the production of hormones in the adrenal gland and can be used in combination with other chemotherapy drugs.
The market for Mitotane is relatively small, as…
The Mitotane Market To See Through Quicker Decision-Making
Over the years, mitotane has become one the preferred choices of treatment for Cushing's syndrome and ACC. The growth of the mitotane market can be attributed to the increased incidence of patient population, which is anticipated to grow significantly in the forecast period.
Furthermore, late recurrence of Cushing's syndrome and late diagnosis and detection also favours the growth of the mitotane market. ACC has been marked with a high recurrence…
Telehealth monitoring to rule the Mitotane Market
The Mitotane Market is expected to grow by leaps and bounds in the forecast period. Nanotechnology's medical application is on the anvil. As such, nanomedicine is an outcome of the technology operating at the molecular, atomic, or supramolecular scale. The broad application areas of nanomedicine include sensing, imaging, diagnosis, and delivery via medical devices. This would certainly keep the healthcare vertical upgraded continuously.
Over the years, mitotane has become one the…
AI-Backed Technologies to Give an Impetus to Mitotane Market
Mitotane Market 2022
The Mitotane Market is expected to grow on a healthy note in the subsequent decade. With value-based care picking up, close to 15% of the entire population is under its umbrella as of now. Programs like "Online Bachelor's Degree in General Studies with a Concentration in Healthcare" is being floated, which could aid professionals to lead in the value-based care strategies. In other words, the future belongs to…
Immersive Technology to guide the growth of Mitotane Market
The Mitotane Market taught to grow sporadically shortly. With improvement in machine-powered analytics, the healthcare vertical is bound to substantiate therein. Machine learning does make caregivers able of putting data to use, thereby enhancing patients’ outcomes along with overall efficiency. This would be the trend in the healthcare vertical going forward.
Over the years, mitotane has become one the preferred choices of treatment for Cushing’s syndrome and ACC. The growth of…
The Mitotane Market to Sail Through Digitized Innovation
The Mitotane Market is estimated to grow on a diligent note in the forecast period. Today, social proof could be equated with digital currency. In other words, people go for digital reviews, signals, and testimonials before deciding on the doctor/hospital. This social proof works better with telehealth, and also goes beyond region-wise obstacles. This would all be about the healthcare vertical going forward.
Over the years, mitotane has become one the…